Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 906 participants.

Also called NCT06571149

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 906 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06571149
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Canada, Finland, France, Germany, Greece, Netherlands, Norway, Portugal, Spain, Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06571149. Randomized; no masking; primary purpose treatment. Start 2025-03-14 (actual); primary completion 2029-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Acronym
DO-IT
Intervention (Drug)
Tenecteplase or Alteplase
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct06571149
Content hash
b999bfc8fc380488aab4b0092ff9f2a68e08c4eb64ce8d2c7aa985d316fcbd72